And another one bites the dust, and another one, and another one. (Queen is hot right now, right?) A study in the Journal of the American Medical Association looks at the impact of a transactional care model for patients hospitalized with heart failure. (JAMA Article) Helping with the transition from hospital to usual sources of care has been widely promoted as having a substantial impact on outcomes. Spoiler alert, oops, there wasn’t any in this trial. The study was conducted in Ontario, Canada in ten hospitals and included about 2500 patients, around 1100 of which were treated at hospitals randomized to receive the intervention. The intervention consisted of a hospital nurse who helped the patient “navigate” the transition to home, including a needs assessment, multidisciplinary referrals for follow-up care, self-care education, a patient-centered discharge summary with a symptom-driven action plan, which certainly sounds impressive, family physician follow-up visit arranged within one week of discharge and referrals to nurse home visits and phone calls. Primary outcomes were time to all-cause hospital readmission or ER visit, death at 3 months or readmission or ER visit rate at 30 days post-discharge. Surveys and scores for post-discharge readiness and quality of care transition and quality of life were also collected. The intervention and normal care groups filled prescriptions at the same rate. No difference in the rate of 3 month composite all-cause readmission, ER visits or death rates between the groups. No difference in time to first readmission, ER visit or death. This despite the fact that the intervention group reported higher preparedness for discharge scores, quality of care transition and quality of life. Was the quality of care transition really any better if meaningful clinical outcomes didn’t improve? This is a tough group of patients, very expensive ones, so it might be hard to make a difference for them, but it is also hard to see the value to a health system in implementing these kinds of interventions if they don’t appear to make any real impact.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Now here is a tale from the glory days of epidemic investing, as the Feds pumped trillions into the economy and a lot of it went to investing, some to...
January 10, 2023
Another merger of two struggling “digital” health companies, which use virtual reality as a product design. Apparently you are less likely to drown in high seas when you are holding...
December 18, 2022
Mercer, a large benefits consulting firm, confirms that health plan premiums are rising in 2023, publishing survey results showing that employers expect an increase of costs by at least 5%....
December 9, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace